7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

NCT05480761 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

312

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of subject enrollment

Conditions

Congenital Sucrase-Isomaltase Deficiency
CSID
Sucrase Isomaltase Deficiency

Interventions

BIOLOGICAL: Sucraid (sacrosidase) Oral Solution 8500 IU/mL

Sponsor

QOL Medical, LLC